Skip to content
10-K

Annual Report

INTEGRA LIFESCIENCES HOLDINGS CORP IART

0000917520-25-000017

← back to feed
Filed
Feb 25, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 24, 2025 77.22M sh
Long Term Debt FY 2024 · Dec 31, 2024 $760.47M
Short Term Investments FY 2024 · Dec 31, 2023 $32.69M
Cash And Equivalents FY 2024 · Dec 31, 2023 $276.4M
Current Liabilities FY 2024 · Dec 31, 2023 $306.98M
Total Liabilities FY 2024 · Dec 31, 2023 $2.19B
Current Assets FY 2024 · Dec 31, 2023 $1.06B
Total Assets FY 2024 · Dec 31, 2023 $3.78B
Shares Diluted FY 2024 · Dec 31, 2022 83.52M sh
Stock Repurchased FY 2024 · Dec 31, 2022 $125M
Capex FY 2024 · Dec 31, 2022 $42.34M
Operating Cash Flow FY 2024 · Dec 31, 2022 $264.47M
Eps Diluted FY 2024 · Dec 31, 2022 $2.16
Eps Basic FY 2024 · Dec 31, 2022 $2.18
Sga Expense FY 2024 · Dec 31, 2022 $616.32M
Net Income FY 2024 · Dec 31, 2022 $180.55M
Operating Income FY 2024 · Dec 31, 2022 $238.92M
Cost Of Revenue FY 2024 · Dec 31, 2022 $587.36M
Revenue FY 2024 · Dec 31, 2022 $1.56B
Stockholders Equity FY 2024 · Dec 31, 2021 $1.68B